APA (7th ed.) Citation

Autio, K. A., Antonarakis, E. S., Mayer, T. M., Shevrin, D. H., Stein, M. N., Vaishampayan, U. N., . . . Scher, H. I. (2021). Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier.

Chicago Style (17th ed.) Citation

Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.

MLA (8th ed.) Citation

Autio, Karen A., et al. Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Elsevier, 2021.